The HiB vaccine is designed to prevent infections caused by the bacterium Haemophilus influenzae type b. This bacterium can lead to severe diseases such as meningitis, pneumonia, and epiglottitis, particularly in young children. The vaccine is composed of polysaccharides from the bacteria's capsule conjugated to a protein carrier to enhance its immunogenicity.
